Skip to main content
OTCMKTS:JMPLY

Johnson Matthey Competitors

$91.76
+1.34 (+1.48 %)
(As of 05/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$91.76
$91.76
50-Day Range
$84.43
$95.72
52-Week Range
$44.21
$95.72
Volume382 shs
Average Volume1,605 shs
Market Capitalization$8.88 billion
P/E Ratio18.10
Dividend Yield1.16%
Beta1.58

Competitors

Johnson Matthey (OTCMKTS:JMPLY) Vs. RDSMY, AHKSY, FMC, OLN, HUN, and CC

Should you be buying JMPLY stock or one of its competitors? Companies in the industry of "chemicals & allied products" are considered alternatives and competitors to Johnson Matthey, including Koninklijke DSM (RDSMY), Asahi Kasei (AHKSY), FMC (FMC), Olin (OLN), Huntsman (HUN), and The Chemours (CC).

Koninklijke DSM (OTCMKTS:RDSMY) and Johnson Matthey (OTCMKTS:JMPLY) are both basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, risk, dividends, institutional ownership and profitability.

Profitability

This table compares Koninklijke DSM and Johnson Matthey's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Koninklijke DSM6.66%9.81%5.27%
Johnson MattheyN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Koninklijke DSM and Johnson Matthey, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Koninklijke DSM11602.63
Johnson Matthey34602.23

Dividends

Koninklijke DSM pays an annual dividend of $0.77 per share and has a dividend yield of 1.7%. Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Koninklijke DSM pays out 59.2% of its earnings in the form of a dividend. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Volatility & Risk

Koninklijke DSM has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Johnson Matthey has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500.

Earnings & Valuation

This table compares Koninklijke DSM and Johnson Matthey's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke DSM$10.09 billion3.22$848.96 million$1.3034.43
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10

Koninklijke DSM has higher earnings, but lower revenue than Johnson Matthey. Johnson Matthey is trading at a lower price-to-earnings ratio than Koninklijke DSM, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.1% of Koninklijke DSM shares are owned by institutional investors. Comparatively, 0.0% of Johnson Matthey shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Koninklijke DSM beats Johnson Matthey on 9 of the 13 factors compared between the two stocks.

Johnson Matthey (OTCMKTS:JMPLY) and Asahi Kasei (OTCMKTS:AHKSY) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Johnson Matthey and Asahi Kasei's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Johnson MattheyN/AN/AN/A
Asahi Kasei4.05%8.80%4.44%

Analyst Recommendations

This is a summary of recent ratings for Johnson Matthey and Asahi Kasei, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Johnson Matthey34602.23
Asahi Kasei01013.00

Dividends

Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Asahi Kasei pays an annual dividend of $0.48 per share and has a dividend yield of 2.1%. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Asahi Kasei pays out 27.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Risk & Volatility

Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Asahi Kasei has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.

Valuation & Earnings

This table compares Johnson Matthey and Asahi Kasei's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10
Asahi Kasei$19.76 billion0.79$956.16 million$1.7412.91

Asahi Kasei has higher revenue and earnings than Johnson Matthey. Asahi Kasei is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are held by institutional investors. Comparatively, 0.1% of Asahi Kasei shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Asahi Kasei beats Johnson Matthey on 11 of the 15 factors compared between the two stocks.

Johnson Matthey (OTCMKTS:JMPLY) and FMC (NYSE:FMC) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Johnson Matthey and FMC's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Johnson MattheyN/AN/AN/A
FMC10.64%30.81%8.57%

Analyst Recommendations

This is a summary of recent ratings for Johnson Matthey and FMC, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Johnson Matthey34602.23
FMC05902.64

FMC has a consensus target price of $130.00, suggesting a potential upside of 11.81%. Given FMC's stronger consensus rating and higher probable upside, analysts clearly believe FMC is more favorable than Johnson Matthey.

Dividends

Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. FMC pays an annual dividend of $1.92 per share and has a dividend yield of 1.7%. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. FMC pays out 31.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. FMC has raised its dividend for 1 consecutive years. FMC is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk & Volatility

Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, FMC has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.

Valuation & Earnings

This table compares Johnson Matthey and FMC's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10
FMC$4.61 billion3.25$477.40 million$6.0919.09

FMC has lower revenue, but higher earnings than Johnson Matthey. Johnson Matthey is trading at a lower price-to-earnings ratio than FMC, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are held by institutional investors. Comparatively, 87.4% of FMC shares are held by institutional investors. 1.0% of FMC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

FMC beats Johnson Matthey on 14 of the 17 factors compared between the two stocks.

Johnson Matthey (OTCMKTS:JMPLY) and Olin (NYSE:OLN) are both mid-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Johnson Matthey and Olin's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Johnson MattheyN/AN/AN/A
Olin-18.47%-9.98%-2.34%

Analyst Recommendations

This is a summary of recent ratings for Johnson Matthey and Olin, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Johnson Matthey34602.23
Olin04902.69

Olin has a consensus target price of $43.1538, suggesting a potential downside of 4.08%. Given Olin's stronger consensus rating and higher probable upside, analysts clearly believe Olin is more favorable than Johnson Matthey.

Dividends

Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Olin pays an annual dividend of $0.80 per share and has a dividend yield of 1.8%. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Olin pays out 133.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Olin has raised its dividend for 1 consecutive years. Olin is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk & Volatility

Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Olin has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.

Valuation & Earnings

This table compares Johnson Matthey and Olin's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10
Olin$6.11 billion1.17$-11,300,000.00$0.6074.98

Johnson Matthey has higher revenue and earnings than Olin. Johnson Matthey is trading at a lower price-to-earnings ratio than Olin, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are held by institutional investors. Comparatively, 84.7% of Olin shares are held by institutional investors. 11.7% of Olin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Johnson Matthey beats Olin on 9 of the 17 factors compared between the two stocks.

Johnson Matthey (OTCMKTS:JMPLY) and Huntsman (NYSE:HUN) are both mid-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Profitability

This table compares Johnson Matthey and Huntsman's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Johnson MattheyN/AN/AN/A
Huntsman16.55%5.27%2.06%

Analyst Recommendations

This is a summary of recent ratings for Johnson Matthey and Huntsman, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Johnson Matthey34602.23
Huntsman031202.80

Huntsman has a consensus target price of $30.6875, suggesting a potential upside of 2.05%. Given Huntsman's stronger consensus rating and higher probable upside, analysts clearly believe Huntsman is more favorable than Johnson Matthey.

Dividends

Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. Huntsman pays an annual dividend of $0.65 per share and has a dividend yield of 2.2%. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. Huntsman pays out 42.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has raised its dividend for 1 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Risk & Volatility

Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, Huntsman has a beta of 1.54, indicating that its share price is 54% more volatile than the S&P 500.

Valuation & Earnings

This table compares Johnson Matthey and Huntsman's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10
Huntsman$6.80 billion0.98$562 million$1.5319.65

Huntsman has lower revenue, but higher earnings than Johnson Matthey. Johnson Matthey is trading at a lower price-to-earnings ratio than Huntsman, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are held by institutional investors. Comparatively, 77.3% of Huntsman shares are held by institutional investors. 5.4% of Huntsman shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Huntsman beats Johnson Matthey on 12 of the 17 factors compared between the two stocks.

Johnson Matthey (OTCMKTS:JMPLY) and The Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and earnings.

Dividends

Johnson Matthey pays an annual dividend of $1.05 per share and has a dividend yield of 1.1%. The Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 3.0%. Johnson Matthey pays out 20.7% of its earnings in the form of a dividend. The Chemours pays out 39.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. The Chemours has raised its dividend for 1 consecutive years. The Chemours is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Profitability

This table compares Johnson Matthey and The Chemours' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Johnson MattheyN/AN/AN/A
The Chemours-2.35%46.27%4.51%

Institutional and Insider Ownership

0.0% of Johnson Matthey shares are held by institutional investors. Comparatively, 74.7% of The Chemours shares are held by institutional investors. 2.7% of The Chemours shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Johnson Matthey has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500. Comparatively, The Chemours has a beta of 2.3, indicating that its share price is 130% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Johnson Matthey and The Chemours, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Johnson Matthey34602.23
The Chemours04402.50

The Chemours has a consensus target price of $31.3750, suggesting a potential downside of 7.09%. Given The Chemours' stronger consensus rating and higher probable upside, analysts clearly believe The Chemours is more favorable than Johnson Matthey.

Valuation & Earnings

This table compares Johnson Matthey and The Chemours' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Johnson Matthey$18.53 billion0.48$324.21 million$5.0718.10
The Chemours$5.53 billion1.01$-52,000,000.00$2.5113.45

Johnson Matthey has higher revenue and earnings than The Chemours. The Chemours is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks.

Summary

The Chemours beats Johnson Matthey on 10 of the 17 factors compared between the two stocks.


Johnson Matthey Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Koninklijke DSM logo
RDSMY
Koninklijke DSM
1.3$44.77+1.1%$32.49 billion$10.09 billion48.66Ex-Dividend
Asahi Kasei logo
AHKSY
Asahi Kasei
1.5$22.47+6.9%$15.66 billion$19.76 billion20.06Gap Up
FMC logo
FMC
FMC
2.1$116.27+1.1%$14.98 billion$4.61 billion30.44Analyst Report
Analyst Revision
Olin logo
OLN
Olin
1.6$44.99+2.1%$7.16 billion$6.11 billion-7.00Analyst Report
Insider Selling
Huntsman logo
HUN
Huntsman
2.3$30.07+1.9%$6.67 billion$6.80 billion6.77Analyst Report
The Chemours logo
CC
The Chemours
1.9$33.77+3.9%$5.59 billion$5.53 billion-46.90Analyst Report
Analyst Revision
Ashland Global logo
ASH
Ashland Global
1.8$85.79+1.8%$5.21 billion$2.33 billion-10.21Analyst Report
W. R. Grace & Co. logo
GRA
W. R. Grace & Co.
2.2$68.30+0.0%$4.53 billion$1.96 billion325.24Earnings Announcement
High Trading Volume
Showa Denko K.K. logo
SHWDY
Showa Denko K.K.
0.5$30.94+10.3%$4.51 billion$8.27 billion-7.18Gap Up
Univar Solutions logo
UNVR
Univar Solutions
0.9$25.58+1.1%$4.34 billion$9.29 billion142.12Earnings Announcement
Analyst Report
Insider Selling
Analyst Revision
News Coverage
Gap Up
Balchem logo
BCPC
Balchem
1.6$133.20+3.7%$4.32 billion$643.71 million52.24
Kuraray logo
KURRY
Kuraray
0.9$33.67+0.0%$3.98 billion$5.26 billion-71.64
Ingevity logo
NGVT
Ingevity
1.7$88.77+3.8%$3.55 billion$1.29 billion20.60Analyst Report
Insider Selling
Innospec logo
IOSP
Innospec
1.8$101.60+3.3%$2.50 billion$1.51 billion68.19Insider Selling
Livent logo
LTHM
Livent
1.3$16.70+1.8%$2.45 billion$388.40 million-185.56
PQ Group logo
PQG
PQ Group
1.7$15.41+1.7%$2.11 billion$1.57 billion48.16Earnings Announcement
Analyst Report
GCP Applied Technologies logo
GCP
GCP Applied Technologies
1.5$25.91+3.5%$1.90 billion$1.01 billion17.99
Hawkins logo
HWKN
Hawkins
2.0$33.04+3.1%$701.18 million$540.20 million10.52Upcoming Earnings
Analyst Downgrade
Loop Industries logo
LOOP
Loop Industries
1.4$7.71+3.2%$327.01 millionN/A-18.36Upcoming Earnings
Liquidmetal Technologies logo
LQMT
Liquidmetal Technologies
0.8$0.08+0.0%$74.16 million$1.37 million0.00
GURE
Gulf Resources
0.6$6.11+0.3%$61.09 million$10.60 million0.00Upcoming Earnings
ESP Resources logo
ESPIQ
ESP Resources
0.0$0.01+1.3%$2.35 millionN/A0.00Gap Up
GETG
Green Earth Technologies
0.5$0.00+0.0%$0.00N/A0.00
ISON
Isonics
0.0$0.00+0.0%$0.00N/A0.00
This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.